Summary
At our institution 686 hemophiliacs are being treated. Of them 402 (59%) are anti-HIV-seropositive. The general use of heat-treated clotting factor products was begun in July 1983, and from May 1984 all patients exclusively used heat-treated clotting factors. Thus, one can assume that infection occurred no later than early 1984 in our patients. Since December 1985 HIV-positive hemophiliacs have regularly been clinically and immunologically examined. Most of the 306 patients who could be investigated were clinically symptom-free at the time of their first visit. However, 45 patients have developed AIDS from 1982 through August 1988. The mean survival time of hemophiliacs with AIDS is less than 6 months. In 36% of those 274 patients who have been followed for a mean period of 14 months the clinical stage of the disease worsened by at least one stage according to the classification system proposed by the Centers for Disease Control. We did not find a correlation between clotting-factor consumption during the years 1984–1986 and the actual clinical stage of the patients. Virus isolation from peripheral blood lymphocytes (PBIs) answered the question whether anti-HIV seropositive hemophiliacs are not only immunized but really infected in many more cases than those revealed by detection of p24 antigen or decline of p24 antibody. Positive viral culture correlated strongly with a drop in CD4+ lymphocytes under the level of 400/µl. However, HIV could not be cultured regularly in advanced cases, suggesting that virus replication in PBLs is not necessarely the cause of depletion of T-helper cells. There is no evidence that the natural history of HIV infection in hemophiliacs is different from that in other HIV-infected patients.
Similar content being viewed by others
Abbreviations
- AIDS:
-
Acquired immunodeficiency syndrome
- ARC:
-
AIDS-related complex
- AZT:
-
Azidothymidine
- CDC:
-
Centers for Disease Control
- CD4 (T4) lymphocytes:
-
Lymphocytes bearing the cluster of differentiation antigen 4
- CD8 (T8) lymphocytes:
-
Lymphocytes bearing the cluster of differentiation antigen 8
- CD5 lymphocytes:
-
Lymphocytes bearing the cluster of differentiation antigen 5
- CD20 lymphocytes:
-
Lymphocytes bearing the cluster of differentiation antigen 20
- CPE:
-
Cytopathic effect
- ELISA:
-
Enzyme linked immunosorbent assay
- F VIII:
-
Blood-clotting factor VIII
- F IX:
-
Blood-clotting factor IX
- HIV:
-
Human immunodeficiency virus
- HNK-1 cells:
-
Human natural killer cells (CD8+ subset)
- IL-2:
-
Interleukin-2
- PHA:
-
Phythemagglutinin
- p24:
-
HIV core protein, molecular weight 24 kd
References
AIDS Group of the United Kingdom Haemophilia Centre Directors (1986) Prevalence of antibody to HTLV-III in haemophiliacs in the United Kingdom. Br Med J 293:175–176
Allain JP (1986) Prevalence of HTLV-III/LAV antibodies in patients with hemophilia and their sexual partners in France. N Engl J Med 315:517–518
Andrews CA, Sullivan JL, Brettler DB, et al. (1987) Isolation of human immunodeficiency virus from haemophiliacs: correlation with clinical symptoms and immunological abnormalities. J Pediatr 111:672–677
Brackmann HH, Hofmann P, Etzel F, Egli H (1976) Home care of haemophilia in West Germany. Thrombos Haemost 35:544–552
Brodt HR, Helm EB, Werner A, et al. (1986) Spontanverlauf der LAV/HTLV-III-Infektion. Verlaufsbeobachtungen bei Personen aus AIDS-Risikogruppen. Dtsch med Wochenschr 111:1175–1180
Castro BA, Weiss CD, Wiviott LD, Levy LA (1988) Optimal conditions for recovery of the human immunodeficiency virus from peripheral mononuclear cells. J Clin Microbiol 26:2371–2376
Centers for Disease Control (1987) Survey of non-U.S. hemophilia treatment centers for HIV seroconversions following therapy with heat-treated factor concentrates. MMWR 36:121–124
Centers for Disease Control (1987) Revision of the Centers for Disease Control surveillance case definition for acquired immunodeficiency syndrome. MMWR 36 [Suppl 15]:1S-15S
Centers for Disease Control (1982) Pneumocystis carinii pneumonia among persons with hemophilia A. MMWR 31:365–367
Centers for Disease Control (1986) Classification system for human T-lymphotropic virus type III lymphadenopathy-associated virus infections. MMWR 35:334–339
Elliot JL, Hoppes WL, Platt MS, Thomas JG, Patel IP, Gansar A (1983) The acquired immunodeficiency syndrome andMycobacterium avium-intracellulare bacteremia in a patient with hemophilia. Ann Intern Med 98:290–293
Eyster ME, Gail MH, Ballard JO, et al. (1987) Natural history of human immunodeficiency virus infections in hemophiliacs: effects of T-cell subsets, platelet counts, and age. Ann Intern Med 107:1–6
Feorino P, Forrester B, Schable C, Warfield D, Schochetman G (1987) Comparison of antigen assay and reverse transcriptase assay for detecting human immunodeficiency virus in culture. J Clin Microbiol 25:2344–2346
Gallo D, Kimpton JS, Dailey PJ (1987) Comparative studies on use of fresh and frozen peripheral blood lymphocyte specimens for isolation of human immunodeficiency virus and effects of cell lysis on isolation efficiency. J Clin Microbiol 25:1291–1294
Goldsmith MF (1986) Hemophilia, beaten on one front, is beset on others. JAMA 256:3200
Jackson JB, Coombs RW, Sannerud K, Rhame FS, Balfour HH jr (1988) Rapid and sensitive viral culture method for human immunodeficiency virus type 1. J Microbiol 26:1416–1418
Jackson JB, Sannerud KJ, Hopsicker JS, Kwok SY, Edson IR, Balfour HH jr (1988) Hemophiliacs with HIV antibody are actively infected. JAMA 260:2236–2239
Johnson RE, Lawrence DN, Evatt BL, et al. (1985) Acquired immunodeficiency syndrome among patients attending hemophilia treatment centers and mortality experience of hemophiliacs in the United States. Am J Epidemiol 121:797–810
Jones P, Hamilton PJ, Bird G, et al. (1985) AIDS and haemophilia: morbidity and mortality in a well-defined population. Br Med J 291:695–699
Lange JMA, Paul DA, Huisman HG, et al. (1986) Persistent HIV-antigenemia and decline of HIV core antibodies associated with transition to AIDS. Br Med J 293:1459–1462
Lederman MM, Ratnoff OD, Scillian JJ, Jones PK, Schacter B (1983) Impaired cell-mediated immunity in patients with classic hemophilia. N Engl J Med 308:79–83
Lissen E, Wichman I, Jimenez JM, Andreu-Kern F (1983) AIDS in haemophilia patients in Spain. Lancet I:992
McCormick A, Tillet H, Bannister B, Emslie J (1987) Surveillance of AIDS in the United Kingdom. Br Med J 295:1466–1469
McGrath KM, Spelman D, Barnett M, Kellner S (1986) Spectrum of HTLV-III infection in a hemophilic cohort treated with blood products from a single manufacturer. Am J Hematol 23:239–245
Menitove JE, Aster RH, Casper JT, et al. (1983) T-lymphocyte subpopulations in patients with classic hemophilia treated with cryoprecipitate and lyophilized concentrates. N Engl J Med 308:83–86
Navarro MD, Leal M, Pineda JA, et al. (1987) Infecciones oportunistas y sarcoma de Kaposi en hemofilicos. Análisls de una serie de pacientes controlados en un hospital y valoración de la conducta médica. Rev Clin Esp 180:188–193
Ragni MV, Winkelstein A, Kingsley L, et al. (1987) 1986 Update of HIV seroprevalence, seroconversion, AIDS incidence, and immunologic correlates of HIV infection in patients with hemophilia A and B. Blood 70:786–790
Schimpf K, Brackmann HH, Kreuz W, et al. (1987) No anti-HIV seroconversion after replacement therapy with pasteurized F VIII concentrate. A study of 151 patients with hemophilia A or von Willebrand's disease. III International Conference on AIDS, Washington D.C., abstract TH.10.4
Schneweis KE, Ackermann A, Friedrich A, Kleim JP, Kornau K, Ruff R, Siefer-Wippermann B (1989) Comarison of the different method for detecting human immunodeficiency virus in HIV-seropositive hemophiliacs. J Med Virol, in press
Stehr-Green JK, Jason JM, Evatt BL, and the hemophilia-associated AIDS multicenter study group (1988) Potential effect of revising the CDC surveillance case definition of AIDS. Lancet 1:520–521
The Pennsylvania AIDS Surveillance Study Group (1987) Geographic differences in hemophilia-associated AIDS incidence in Pennsylvania. Blood 70:1208–1210
Vilmer E, Barre-Sinoussi F, Rouzioux C, et al. (1984) Isolation of new lymphotropic retrovirus from two siblings with haemophilia B, one with AIDS. Lancet I:753–757
Walker CM, Moddy DJ, Stites DP, Levy JA (1986) CD8+ lymphocytes can control HIV-infection in vitro by suppressing replication. Science 234:1563–1566
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kamradt, T., Niese, D., Schneweis, K.E. et al. Natural history of HIV-infection in hemophiliacs: Clinical, immunological, and virological findings. Klin Wochenschr 67, 1033–1041 (1989). https://doi.org/10.1007/BF01727005
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01727005